"Mission: To achieve excellence in health, healing and learning through working together Vision: Healthy people, healthy communities – for generations"

During the past decade, Nova Scotia Health Authority conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 1 clinical trials were completed. i.e. 3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nova Scotia Health Authority" #1 sponsor was "Nova Scotia Health Authority" with 18 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Ottawa Hospital Research Institute" with 4 trials sponsored, "Population Health Research Institute" with 3 trials sponsored and "University Health Network, Toronto" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Scotia Health Authority" #1 collaborator was "Nova Scotia Health Authority" with 8 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 6 trials as a collaborator, "Dalhousie University" with 4 trials as a collaborator, "IWK Health Centre" with 2 trials as a collaborator and "Nova Scotia Health Research Foundation" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Nova Scotia Health Authority" are "Bipolar Disorder" (3 trials), "Cancer" (3 trials), "Venous Thromboembolism" (3 trials), "Burnout, Professional" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Nova Scotia Health Authority" in a lesser frequency.

Most popular intervention types in "Nova Scotia Health Authority" are "Drug" (32 trials), "Other" (12 trials), "Procedure" (12 trials), "Behavioral" (11 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Anatomic Glenoid Reconstruction" (2 trials), "Dexamethasone" (2 trials), "Enzalutamide" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nova Scotia Health Authority" are 64 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nova Scotia Health Authority". 2 are not yet recruiting, 29 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Nova Scotia Health Authority, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Nova Scotia Health Authority, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 27 trials that are defined as “Not Applicable".